NEOGENOMICS INC Quarterly Interest Expense in USD from Q1 2011 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Neogenomics Inc quarterly/annual Interest Expense history and growth rate from Q1 2011 to Q1 2024.
  • Neogenomics Inc Interest Expense for the quarter ending March 31, 2024 was $1.69M, a 4.1% decline year-over-year.
  • Neogenomics Inc Interest Expense for the twelve months ending March 31, 2024 was $6.84M, a 15% decline year-over-year.
  • Neogenomics Inc annual Interest Expense for 2023 was $6.91M, a 8.89% decline from 2022.
  • Neogenomics Inc annual Interest Expense for 2022 was $7.58M, a 7.77% decline from 2021.
  • Neogenomics Inc annual Interest Expense for 2021 was $8.22M, a 17.1% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $6.84M $1.69M -$72K -4.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-30
Q4 2023 $6.91M $10.5M +$5.3M +102% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-20
Q3 2023 $1.61M -$2.84M -$2.98M -2143% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $4.59M -$2.52M -$3.45M -373% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $8.04M $1.76M +$456K +35.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-30
Q4 2022 $7.58M $5.22M +$370K +7.64% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-20
Q3 2022 $7.21M $139K -$1.16M -89.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $8.37M $926K +$24K +2.66% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $8.34M $1.3M +$124K +10.5% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $8.22M $4.85M +$2.65M +121% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-20
Q3 2021 $5.57M $1.3M -$1.16M -47.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $6.73M $902K -$646K -41.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $7.38M $1.18M +$358K +43.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $7.02M $2.19M +$1.81M +477% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-24
Q3 2020 $5.21M $2.46M +$2.26M +1111% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $2.95M $1.55M +$244K +18.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $2.71M $819K -$1.01M -55.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $3.71M $380K -$1.08M -74% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-25
Q3 2019 $4.8M $203K -$1.67M -89.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 $6.47M $1.3M -$103K -7.32% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 $6.57M $1.83M +$340K +22.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-29
Q4 2018 $6.23M $1.46M Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $1.87M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 $1.41M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $1.49M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q1 2014 $969K $265K -$20K -7.02% Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-12
Q4 2013 $989K $241K -$68K -22% Oct 1, 2013 Dec 31, 2013 10-K/A 2016-04-18
Q3 2013 $1.06M $231K -$60K -20.6% Jul 1, 2013 Sep 30, 2013 10-Q 2013-10-30
Q2 2013 $1.12M $232K -$56K -19.4% Apr 1, 2013 Jun 30, 2013 10-Q 2013-08-02
Q1 2013 $1.17M $285K +$27K +10.5% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 $1.15M $309K +$87K +39.2% Oct 1, 2012 Dec 31, 2012 10-K 2014-02-24
Q3 2012 $1.06M $291K +$106K +57.3% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-30
Q2 2012 $953K $288K +$109K +60.9% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-02
Q1 2012 $844K $258K +$76K +41.8% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-13
Q4 2011 $768K $222K Oct 1, 2011 Dec 31, 2011 10-K 2014-02-24
Q3 2011 $185K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-05
Q2 2011 $179K Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-08-15
Q1 2011 $182K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.